[SRNE] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
14-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- -32.18%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 21,193 151,856 8,152 4,590 3,825 460 584 81.90%
PBT -213,781 15,315 -64,833 -13,760 -36,359 -21,911 -4,845 87.92%
Tax -6,274 -36,038 -896 36,314 -1,702 10 15 -
NP -203,540 9,061 -60,923 -45,811 -34,657 -21,911 -4,845 86.39%
Tax Rate - 235.31% - - - - - -
Total Cost 224,733 142,795 69,075 50,401 38,482 22,371 5,429 85.93%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -960.41 5.97 -747.34 -998.06 -906.07 -4,761.79 -830.00 2.46%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -1.92 0.13 -1.21 -1.24 -1.30 -1.46 -0.42 28.81%
EPS Diluted -1.92 0.13 -1.21 -1.24 -1.30 -1.46 -0.42 28.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.